Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
459 Treatment management of BRAF-mutant melanoma patients following tumor recurrence upon adjuvant therapy: A multicenter real-world cohort study from the prospective skin cancer registry ADOREG
Compose a Response to This Article
Other responses
No responses have been published for this article.
